Resveratrol and endothelial nitric oxide. (Q38258814)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

review article

2 references

8 April 2021

Resveratrol and endothelial nitric oxide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

0 references

1 reference

8 April 2021

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Huige Li

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Ulrich Förstermann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

language of work or name

English

0 references

publication date

9 October 2014

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

8 April 2021

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

8 April 2021

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

16102-16121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution

21 February 2020

copyright license

1 reference

8 April 2021

0 references

Nitric oxide synthases: regulation and function

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Molecular mechanisms underlying the activation of eNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Nitric oxide in the pathogenesis of vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Prevention of atherosclerosis by interference with the vascular nitric oxide system

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Hypertension in mice lacking the gene for endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol induces mitochondrial biogenesis in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Overexpression of endothelial nitric oxide synthase prevents diet-induced obesity and regulates adipocyte phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Chemosensitization of tumors by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol: one molecule, many targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol: a multitargeted agent for age-associated chronic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Substrate-specific activation of sirtuins by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Mechanism of human SIRT1 activation by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol is not a direct activator of SIRT1 enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Evidence for a common mechanism of SIRT1 regulation by allosteric activators

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Small-molecule allosteric activators of sirtuins

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol activates SIRT1 in a Lamin A-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

SIRT1 and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

An acetylome peptide microarray reveals specificities and deacetylation substrates for all human sirtuin isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Cardiovascular effects and molecular targets of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol as a gene regulator in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol stimulates AMP kinase activity in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

AMPK and SIRT1: a long-standing partnership?

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Mammalian sirtuins: biological insights and disease relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i).

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol prevents endothelial dysfunction and aortic superoxide production after trauma hemorrhage through estrogen receptor-dependent hemeoxygenase-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Association of SIRT1 expression with shear stress induced endothelial progenitor cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

NAD-dependent histone deacetylase, SIRT1, plays essential roles in the maintenance of hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Effects of intravenous ABT-870 (iron (III)-hydroxide oligosaccharide) on mean arterial pressure and heart rate in the anaesthetized beagle: comparison with other iron-containing haematinic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through a SIRT1-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Endothelial nitric oxide synthase in vascular disease: from marvel to menace

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Oxidative stress in vascular disease and its pharmacological prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Essential role of ER-alpha-dependent NO production in resveratrol-mediated inhibition of restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Histone deacetylase 3 antagonizes aspirin-stimulated endothelial nitric oxide production by reversing aspirin-induced lysine acetylation of endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Pharmacology and clinical pharmacology of methylarginines used as inhibitors of nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

ADMA and the role of the genes: lessons from genetically modified animals and human gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Piceatannol is more effective than resveratrol in restoring endothelial cell dimethylarginine dimethylaminohydrolase expression and activity after high-glucose oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Genetic ablation of caveolin-1 confers protection against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol ameliorates high-glucose-induced hyperpermeability mediated by caveolae via VEGF/KDR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol increases vascular oxidative stress resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Cardiovascular protective effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Sirt1 regulates aging and resistance to oxidative stress in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Silent information regulator 1 protects the heart from ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Anti‐inflammatory effects of resveratrol: possible role in prevention of age‐related cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES191016102

Resveratrol attenuates ovariectomy-induced hypertension and bone loss in stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

12 December 2020

Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta

1 reference

12 December 2020

Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice

1 reference

12 December 2020

Effect of red wine and wine polyphenol resveratrol on endothelial function in hypercholesterolemic rabbits

1 reference

12 December 2020

Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

1 reference

12 December 2020

Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels.

1 reference

12 December 2020

Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model

1 reference

12 December 2020

Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages

1 reference

12 December 2020

Endothelial function and dysfunction: testing and clinical relevance

1 reference

12 December 2020

Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice

1 reference

12 December 2020

Effects of resveratrol on number and activity of endothelial progenitor cells from human peripheral blood.

1 reference

12 December 2020

Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4).

1 reference

12 December 2020

Resveratrol-induced augmentation of telomerase activity delays senescence of endothelial progenitor cells.

1 reference

12 December 2020

10.3390/MOLECULES191016102

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

PubMed publication ID

25302702

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25302702%20AND%20SRC:MED&resulttype=core&format=json